Practical issues in counseling healthy women about their breast cancer risk and use of tamoxifen citrate

被引:6
|
作者
Smedira, HJ [1 ]
机构
[1] Cleveland Clin Fdn, Dept Gen Surg, Cleveland, OH 44195 USA
关键词
D O I
10.1001/archinte.160.20.3034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Advances in the detection and medical and surgical treatment of breast cancer have caught the attention of the media and the public. Such widespread media attention has been a mixed blessing, however; the anxiety engendered may actually lead to poorer compliance. with breast cancer screening recommendations and may jeopardize early detection. Despite being better informed, many women seem to fatalistically await the development of breast cancer.
引用
收藏
页码:3034 / 3042
页数:9
相关论文
共 50 条
  • [1] TAMOXIFEN TRIAL IN HEALTHY WOMEN AT RISK OF BREAST-CANCER
    COSTA, A
    LANCET, 1993, 342 (8868): : 444 - 444
  • [2] Counseling Women About Breast Cancer Screening
    Ebell, Mark H.
    Lin, Kenneth W.
    AMERICAN FAMILY PHYSICIAN, 2016, 93 (08) : 652 - 653
  • [3] Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: A framework for personalized risk assessment and counseling
    Ellent T. Matloff
    Kristen M. Shannon
    Anne Moyer
    Nananda F. Col
    Journal of Cancer Education, 2007, 22 : 10 - 14
  • [4] Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: A framework for personalized risk assessment and counseling
    Matloff, Ellen T.
    Shannon, Kristen M.
    Moyer, Anne
    Col, Nananda F.
    JOURNAL OF CANCER EDUCATION, 2007, 22 (01) : 10 - 14
  • [5] Tamoxifen for women at high risk of breast cancer
    Nazarali, Safia A.
    Narod, Steven A.
    BREAST CANCER-TARGETS AND THERAPY, 2014, 6 : 29 - 36
  • [6] Risk of contralateral breast cancer after tamoxifen use among Danish women
    Mellernkjaer, Lene
    Steding-Jessen, Marianne
    Frederiksen, Kirsten
    Andersson, Michael
    Ejlertsen, Bent
    Jensen, Maj-Britt
    Olsen, Jorgen H.
    ANNALS OF EPIDEMIOLOGY, 2014, 24 (11) : 843 - 848
  • [7] Tamoxifen and breast density in women at increased risk of breast cancer
    Cuzick, J
    Warwick, J
    Pinney, E
    Warren, RML
    Duffy, SW
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (08): : 621 - 628
  • [8] When should tamoxifen be offered for breast cancer prevention? A practical look at risk-benefit issues
    Finkelstein, M
    Love, N
    POSTGRADUATE MEDICINE, 1999, 105 (06) : 61 - +
  • [9] Reducing the risk of breast cancer with tamoxifen in women at increased risk
    Vogel, VG
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 87S - 92S
  • [10] Tamoxifen for breast cancer risk reduction: Is it acceptable to women at risk?
    Melnikow, J
    Paterniti, D
    Jim, N
    Kuenneth, C
    Birch, S
    Kuppermann, M
    Azari, R
    DeGregorio, M
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 303 - 304